Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2022 ∙ Craiu, D. Rener Primec, Z. Lagae, L. Vigevano, F. Trinka, E. Specchio, N. Bakhtadze, S. Cazacu, C. Golli, T. Zuberi, S. M.
Vaccination and childhood epilepsies
Newborn Children Adolescents COVID-19 Diphtheria Tetanus Pertussis Measles Mumps Rubella Influenza Haemophilus influenzae type B Safety Coverage Acceptance
Rating:
Critically low
2022 ∙ Gebeyehu, N. A. Asmare Adela, G. Dagnaw Tegegne, K. Birhan Assfaw, B.
Vaccination dropout among children in Sub-Saharan Africa: Systematic review and meta-analysis
Africa Children Coverage
Rating:
Not applicable
2022 ∙ Huang, Y. Z. Kuan, C. C.
Vaccination to reduce severe COVID-19 and mortality in COVID-19 patients: a systematic review and meta-analysis
Adults Older adults COVID-19 Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Ali, H. A. Hartner, A. M. Echeverria-Londono, S. Roth, J. Li, X. Abbas, K. Portnoy, A. Vynnycky, E. Woodruff, K. Ferguson, N. M. Toor, J. Gaythorpe, K. A.
Vaccine equity in low and middle income countries: a systematic review and meta-analysis
All age groups Low and Middle Income Countries Ethical issues Coverage
Rating:
Not applicable
2022 ∙ Li, L. Wood, C. E. Kostkova, P.
Vaccine hesitancy and behavior change theory-based social media interventions: A systematic review
Children Adolescents Adults Parents/caregivers Acceptance Coverage
Rating:
Not applicable
2022 ∙ Daniels, D. Imdad, A. Buscemi-Kimmins, T. Vitale, D. Rani, U. Darabaner, E. Shaw, A. Shaw, J.
Vaccine hesitancy in the refugee, immigrant, and migrant population in the United States: A systematic review and meta-analysis
Americas United States of America Adults Older adults Acceptance Coverage Ethical issues
Rating:
Not applicable
2022 ∙ Ophir, Y. Walter, N. Walter, D. Velho, R. M. Lokmanoglu, A. D. Pruden, M. L. Andrews, E. A.
Vaccine Hesitancy Under the Magnifying Glass: A Systematic Review of the Uses and Misuses of an Increasingly Popular Construct
All age groups Healthcare workers Acceptance
Rating:
Not applicable
2022 ∙ Pipitone, G. Rindi, L. V. Petrosillo, N. Foti, N. A. M. Caci, G. Iaria, C. Donno, D. R. Boumis, E. Paviglianiti, G. Taglietti, F.
Vaccine-Induced Subacute Thyroiditis (De Quervain's) after mRNA Vaccine against SARS-CoV-2: A Case Report and Systematic Review
Adults COVID-19 Safety
Rating:
Critically low
2022 ∙ Bollaerts, K. Fletcher, M. A. Suaya, J. A. Hanquet, G. Baay, M. Gessner, B. D.
Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials
Newborn Older adults Pneumococcal disease Efficacy/effectiveness
Rating:
Critically low
2022 ∙ Scendoni, R. Bury, E. Ribeiro, I. L. A. Cameriere, R. Cingolani, M.
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines' immunogenicity
All age groups Efficacy/effectiveness Safety
Rating:
Critically low
Loading...